YIELD10 BIOSCI Cash Flow - Annual (NASDAQ:YTEN)

Add to My Stocks
$1.69 $0 (0%) YTEN stock closing price Apr 23, 2018 (Closing)

The YIELD10 BIOSCI cash flow statement is one of the three reports that the company generates every quarter. The profit-loss statement shows YIELD10 BIOSCI profits, the balance sheet shows YIELD10 BIOSCI debt, and the cash flow statement reflects the liquidity and solvency of a firm. This statement reflects the company's ability to generate cash flows. YIELD10 BIOSCI had cash and cash equivalents of $7.3M at beginning of the year and $14.48M at year end for 2017. YIELD10 BIOSCI cash flow analysis tells whether or not the company has enough cash for its day to day activities, and for investing for future growth. YIELD10 BIOSCI had an outflow of $-8.2M from operating activities, $15.27M inflow due to financing activities, and $- outflow due to investing activities for 2017.

View details of YIELD10 BIOSCI cash flows for latest & last 10 financial years
show more
Quarterly
Annual
View Previous Years
View Next Years
Fiscal year is Jan - Dec2017201620152014201320122011201020092008
Net Income Cash Flow
-9.39M-7.6M-23.68M-26.76M-30.5M3.63M-38.78M-38.8M-37.95M-36M
Depreciation Depletion Amortization Cash-Flow-----1.29M1.5M1.64M2.73M3.73M
Net Increase (Decrease) in Assets Liabilities-0.49M--1.07M-0.9M-1.47M-40.87M--4.45M9.04M
Cash From (used in) Discontinued Operations--9.83M--0.84M------
Other Adjustments Net1.48M1.52M2.62M3.48M4.4M4.21M5.16M5.13M5.01M4.83M
Net Cash from (used by) Operating Activities
-8.2M-14.7M-21.86M-24.53M-26.64M-31.73M-31.73M-31.99M-25.75M-18.39M
Increase (Decrease) in Prop Plant And Equipment-0.01M-0.75M-0.61M-0.12M-0.37M-0.38M-0.89M-0.9M-1.94M-0.79M
Acquisition Disposition of Subsidiaires----------
Increase (Decrease) in Investments---11.5M20.18M25.37M-8.01M32.31M-16.9M21.97M
Other Cash Inflow (Outflow) from Investment Activities-10.5M---0.02M---0.02M--0.09M
Net Cash from (used by) Investment Activities
-9.75M-0.61M11.67M19.78M25.01M-8.9M31.37M-18.85M21.08M
Issuance (Purchase) of Equity Shares15.28M-14.7M25.21M--49.4M2.33M29.23M-
Issuance (Repayment) of Debt Securities----------
Increase (Decrease) in Bank & Other Borrowings----------
Payment of Dividends & Other Cash Distributions----------
Other Cash from (used by) Financing Activities-0.01M---------
Net Cash from (used by) Financing Activities
15.27M-14.7M25.21M--49.4M2.33M29.23M-
Effect of Exchange Rate Changes on Cash--0.01M---0.02M-0.01M-0.01M-0.01M--
Net Change in Cash & Cash Equivalents
7.17M-4.96M-7.77M12.34M-6.87M-6.7M8.75M1.71M-15.38M3.5M
Cash & Equivalents at Beginning of Year7.3M12.26M20.04M7.69M14.57M21.27M12.52M10.81M26.19M22.68M
Cash & Equivalents at Year End14.48M7.3M12.26M20.04M7.69M14.57M21.27M12.52M10.81M26.19M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

Click here to view our Honeywell financial analysis

YIELD10 BIOSCI stock price history provides insight into historical stock price fluctuations, and YIELD10 BIOSCI stock comparison chart enables peer comparison. Some of the key terms used in the statement of cash flows are:

  • Net Change in Cash and Cash Equivalents: A positive net change in cash and cash equivalents shows that YIELD10 BIOSCI is able to meet its expenditure and grow cash at hand which demonstrates the financial strength of the company's balance sheet. Also see - YIELD10 BIOSCI stock price movement.
  • Cash Flow from operating activities: This is the cash that the company receives from ongoing operations. YIELD10 BIOSCI lost $-8.2M cash from operations. It is important to check this to see where the company is getting its money from.
  • Growth companies, typically most tech companies; spend heavily on investing activities and this figure stood at $- for YTEN stock. Sometimes a company might have a negative overall cash flow which may not be really bad if it is due to investment expenses. Hence it is important to check the cash flow from investment activities.
  • Cash flow from financing activities shows the flow of cash between YIELD10 BIOSCI and its owners and creditors and was $15.27M for 2017. Financing activities allow a company to raise capital, and repay bondholders.

Key Financial Ratios For YIELD10 BIOSCI Cash Flow